Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bomalaski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Current Opinion in Obstetrics & Gynecology|February 27, 1999
The treatment of recurrent ovarian carcinoma: balancing patient desires, therapeutic benefit, cost containment and quality of lifeJ J Bomalaski
Obstetrics and Gynecology Clinics of North America|January 5, 2002
Diagnosis and management of vulvar and vaginal intraepithelial neoplasiaR J Cardosi, J J Bomalaski, M S Hoffman
Current Opinion in Obstetrics & Gynecology|February 15, 2001
MammographyJ J Bomalaski, M Tabano, L Hooper, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1984
Pleural ascites without abdominal fluid: surgical considerationsR S Hartz, J Bomalaski, J LoCicero, et al.
British Journal of Cancer|December 3, 2011
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetaseM P Kelly, A A Jungbluth, B-W Wu, et al.
Obstetrics and Gynecology|January 1, 1992
Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometriumR M Bigsby, A X Li, J Bomalaski, et al.
Cell Death & Disease|January 19, 2013
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastomaN Syed, J Langer, K Janczar, et al.
British Journal of Cancer|April 5, 2012
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseL G Feun, A Marini, G Walker, et al.
Cell Death & Disease|July 6, 2012
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosisB Delage, P Luong, L Maharaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Opinion in Obstetrics & Gynecology|February 27, 1999
The treatment of recurrent ovarian carcinoma: balancing patient desires, therapeutic benefit, cost containment and quality of lifeJ J Bomalaski
Obstetrics and Gynecology Clinics of North America|January 5, 2002
Diagnosis and management of vulvar and vaginal intraepithelial neoplasiaR J Cardosi, J J Bomalaski, M S Hoffman
Current Opinion in Obstetrics & Gynecology|February 15, 2001
MammographyJ J Bomalaski, M Tabano, L Hooper, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1984
Pleural ascites without abdominal fluid: surgical considerationsR S Hartz, J Bomalaski, J LoCicero, et al.
British Journal of Cancer|December 3, 2011
Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetaseM P Kelly, A A Jungbluth, B-W Wu, et al.
Obstetrics and Gynecology|January 1, 1992
Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometriumR M Bigsby, A X Li, J Bomalaski, et al.
Cell Death & Disease|January 19, 2013
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastomaN Syed, J Langer, K Janczar, et al.
British Journal of Cancer|April 5, 2012
Negative argininosuccinate synthetase expression in melanoma tumours may predict clinical benefit from arginine-depleting therapy with pegylated arginine deiminaseL G Feun, A Marini, G Walker, et al.
Cell Death & Disease|July 6, 2012
Promoter methylation of argininosuccinate synthetase-1 sensitises lymphomas to arginine deiminase treatment, autophagy and caspase-dependent apoptosisB Delage, P Luong, L Maharaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 17, 2018
Phase III randomized study of second line ADI-PEG 20 plus best supportive care versus placebo plus best supportive care in patients with advanced hepatocellular carcinomaG K Abou-Alfa, S Qin, B-Y Ryoo, et al.
Pageof 1